Christopher Stone
2018
In 2018, Christopher Stone earned a total compensation of $2.1M as Vice President, General Counsel and Secretary at PDL BioPharma, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $500,940 |
|---|---|
| Option Awards | $1,137,555 |
| Salary | $483,000 |
| Other | $10,000 |
| Total | $2,131,495 |
Stone received $1.1M in option awards, accounting for 53% of the total pay in 2018.
Stone also received $500.9K in non-equity incentive plan, $483K in salary and $10K in other compensation.
Rankings
In 2018, Christopher Stone's compensation ranked 5,386th out of 14,244 executives tracked by ExecPay. In other words, Stone earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,386 out of 14,244 | 62nd |
Division Manufacturing | 2,032 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 742 out of 2,128 | 65th |
Industry group Drugs | 622 out of 1,817 | 66th |
Industry Biological Products, Except Diagnostic Substances | 127 out of 339 | 63rd |
Source: SEC filing on April 30, 2019.
Stone's colleagues
We found four more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2018.